Literature DB >> 25135153

Cryptococcosis-related deaths and associated medical conditions in the United States, 2000-2010.

Noel C Barragan1, Frank Sorvillo, Tony Kuo.   

Abstract

Cryptococcosis is an invasive mycotic infection primarily affecting immunocompromised individuals. The objective of this study was to describe cryptococcosis mortality and associated medical conditions in the US for the period 2000-2010. Cryptococcosis-related deaths were identified from the national multiple-cause-of-death dataset. Mortality trends and comparison analyses were performed on overall cases of cryptococcosis and by subset [i.e. clinical manifestations of disease and human immunodeficiency virus (HIV) status]. A matched case-control analysis was also conducted to describe the associations between this disease and comorbid medical conditions. A total of 3210 cryptococcosis-related deaths were identified. Cerebral cryptococcosis was the most commonly reported clinical manifestation of the disease. Approximately one-fifth of the decedents (n = 616) had a co-diagnosis of HIV. Mortality rates were highest among men, blacks, Hispanics, Native Americans and older adults. Poisson regression analysis indicated a 6.52% annual decrease in mortality rates for the study period. HIV (MOR = 35.55, 95% CI 27.95-45.22) and leukaemia (MOR = 16.10, 95% CI 11.24-23.06) were highly associated with cryptococcosis-related deaths. Cryptococcosis mortality declined significantly during 2000-2010. However, the disease continues to cause appreciable mortality in the US. With the majority of decedents having no HIV co-diagnosis, there is still much to be learned about the epidemiology of this mycosis.
© 2014 Blackwell Verlag GmbH.

Entities:  

Keywords:  Cryptococcosis; disease; epidemiology; fungal; human; infectious

Mesh:

Year:  2014        PMID: 25135153     DOI: 10.1111/myc.12238

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  9 in total

1.  A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States.

Authors:  Kieren A Marr; Yifei Sun; Andrej Spec; Na Lu; Anil Panackal; John Bennett; Peter Pappas; Darin Ostrander; Kausik Datta; Sean X Zhang; Peter R Williamson
Journal:  Clin Infect Dis       Date:  2020-01-02       Impact factor: 9.079

2.  Rising to the challenge of multiple Cryptococcus species and the diseases they cause.

Authors:  Alexander Idnurm; Xiaorong Lin
Journal:  Fungal Genet Biol       Date:  2015-05-14       Impact factor: 3.495

3.  Cryptococcosis in Patients with Nephrotic Syndrome: A Pooled Analysis of Cases.

Authors:  Wenjie Fang; Nan Hong; Yingfang Li; Jia Liu; Lei Zhang; Weiwei Jiang; Bo Qiu; Jianping Xu; Wanqing Liao; Min Chen; Weihua Pan
Journal:  Mycopathologia       Date:  2017-01-04       Impact factor: 2.574

4.  Increased cryptococcal meningitis mortality among HIV negative, non-transplant patients: a single US center cohort study.

Authors:  Gabriel Motoa; Amy Pate; Daniel Chastain; Sarah Mann; Gregory S Canfield; Carlos Franco-Paredes; Andrés F Henao-Martínez
Journal:  Ther Adv Infect Dis       Date:  2020-07-08

5.  Risk Factors for Cryptococcal Meningitis: A Single United States Center Experience.

Authors:  Andrés F Henao-Martínez; Lilyana Gross; Bryan Mcnair; Bruce McCollister; Kristen DeSanto; Jose G Montoya; Leland Shapiro; J David Beckham
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

6.  The prevalence and mortality of cryptococcal meningitis in patients with autoimmune diseases: a systematic review and meta-analysis.

Authors:  Jing Zhao; Weipin Weng; Chunli Chen; Jie Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-07-14       Impact factor: 3.267

7.  Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization.

Authors:  Giuseppe Ianiri; Alexander Idnurm
Journal:  MBio       Date:  2015-03-31       Impact factor: 7.867

8.  The CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis.

Authors:  Y Ding; P Li; Q He; H Wei; T Wu; D Xia; M Tan; Y Shi; X Su
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-29       Impact factor: 3.267

9.  The clinical profiles and outcomes of HIV-negative cryptococcal meningitis patients in type II diabetes mellitus.

Authors:  Hang Li; Xiaojing Li; Lei Zhang; Wenjie Fang; Keming Zhang; Amir Arastehfar; Macit Ilkit; Dongying Hu; Xianzhen Chen; Huiwei Wang; Liyan Ling; Jianjun Lin; Bin Xu; Wanqing Liao; Weihua Pan; Qilong Zhang
Journal:  BMC Infect Dis       Date:  2021-02-27       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.